VJHemOnc is committed to improving our service to you

ASCO 2019 | Rituximab combination therapy for waldenström’s macroglobulinemia

VJHemOnc is committed to improving our service to you

Jithma Abeykoon

Jithma Abeykoon, MD, PhD, of the Mayo Clinic, Rochester, MN, gives an overview of rituximab-based combination therapy outcomes in patients with waldenström’s macroglobulinemia. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter